Jeffrey R Curtis

Title: Innovations by Jeffrey R Curtis in Cardiovascular and Infection Risk Assessment

Introduction

Jeffrey R Curtis is an accomplished inventor based in Birmingham, AL (US). He has made significant contributions to the field of medical diagnostics, particularly in assessing risks associated with inflammatory diseases. His work focuses on improving patient outcomes through innovative methods.

Latest Patents

Curtis holds a patent for "Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients." This patent outlines methods for evaluating the risk of infection or cardiovascular disease (CVD) in individuals suffering from inflammatory diseases, such as rheumatoid arthritis. The methods involve performing immunoassays to generate scores based on quantitative data for the expression of inflammatory biomarkers, which can guide treatment decisions.

Career Highlights

Jeffrey R Curtis is associated with Laboratory Corporation of America Holdings, where he applies his expertise in medical diagnostics. His work has been instrumental in developing methods that enhance the understanding of disease risks in patients with inflammatory conditions.

Collaborations

Curtis collaborates with Kerri Ford, contributing to advancements in the field of medical research and diagnostics. Their combined efforts aim to improve patient care and treatment strategies.

Conclusion

Jeffrey R Curtis's innovative work in assessing cardiovascular and infection risks in rheumatoid arthritis patients showcases the importance of research in improving healthcare outcomes. His contributions continue to influence the medical field positively.